(Sibeprenlimab), an APRIL-Neutralizing IgG2 November 13, 2018 | International Society for Influenza and Respiratory Viruses (ISIRV) Antiviral Drug Development Conference Hershberger, et. al.(Sibeprenlimab), an APRIL-Neutralizing IgG2 Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine Hay, Patrick Smith, Frank Engler, Jose Trevejo, Zach Shriver, David Oldach
